Does FOSPHENYTOIN Cause Infusion site extravasation? 19 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 19 reports of Infusion site extravasation have been filed in association with FOSPHENYTOIN (CEREBYX). This represents 1.4% of all adverse event reports for FOSPHENYTOIN.
19
Reports of Infusion site extravasation with FOSPHENYTOIN
1.4%
of all FOSPHENYTOIN reports
0
Deaths
2
Hospitalizations
How Dangerous Is Infusion site extravasation From FOSPHENYTOIN?
Of the 19 reports, 2 (10.5%) required hospitalization.
Is Infusion site extravasation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FOSPHENYTOIN. However, 19 reports have been filed with the FAERS database.
What Other Side Effects Does FOSPHENYTOIN Cause?
Drug ineffective (406)
Off label use (164)
Status epilepticus (82)
Multiple-drug resistance (77)
Cardiac arrest (72)
Seizure (70)
Drug ineffective for unapproved indication (63)
Hypotension (56)
Toxicity to various agents (53)
Bradycardia (39)
What Other Drugs Cause Infusion site extravasation?
HUMAN IMMUNOGLOBULIN G (822)
INFLIXIMAB (435)
INFLIXIMAB-DYYB (328)
TREPROSTINIL (256)
VEDOLIZUMAB (199)
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN (185)
REMDESIVIR (144)
FERRIC CARBOXYMALTOSE (118)
RITUXIMAB (82)
NATALIZUMAB (70)
Which FOSPHENYTOIN Alternatives Have Lower Infusion site extravasation Risk?
FOSPHENYTOIN vs FOSTAMATINIB
FOSPHENYTOIN vs FOSTEMSAVIR TROMETHAMINE
FOSPHENYTOIN vs FOTEMUSTINE
FOSPHENYTOIN vs FRAMYCETIN
FOSPHENYTOIN vs FREMANEZUMAB